Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nsc Stock In Focus Buying Pressure Builds 20260403 1 Dnli Stock Analysis Denali Therapeutics Inc. Gains 4.93 Percent To 20.65 Level 20260403 1 What Upcoming Catalysts Matter For Tnl Mediagene Tnmg Stock Price At 1.65 Up 3.00 20260407 Will Vir Biotechnology Vir Stock Outperform S P 500 Price At 9.77 Up 2.61 20260409 Is Brook Brp Bepi Stock Showing Strength Price At 15.56 Up 0.84 20260408 The balance sheet strength behind Phoenix FENG results Is GlobalFoundries GFS a once in a decade opportunity Smart Money Flows 20260508 How KKR Co KKRD talent strategy drives results KKRD Q3 Earnings Series D 625 Preferred Declares Quarterly Dividend International Business Machines Corporation IBM Strategic Positioning in Sovereign AI and Enterprise Governance AES AES Corp posts narrow Q3 2025 EPS miss shares register minimal gain in daily trading AES Corp AES Stock Volume Weight Institutional Demand 20260420 Zeo Energy ZEO Stock Closes Position Breakout Watch 20260420 Equinix Inc EQIX Q1 2026 Earnings Preview Wall Street Consensus Metrics and Growth Outlook Analysis CVS Health CVS posts 88 percent Q4 2025 EPS beat shares dip 117 percent on cautious investor sentiment How Riot Platforms RIOT revenue breaks down and what it means Eye on Rally 20260508 BOOT Boot Barn Q1 2026 EPS tops estimates by 6 percent shares climb 337 percent on upbeat investor reaction BENF Beneficient trounces first quarter 2026 loss estimates shares rise more than 7 percent today Moodys Corporation MCO AI Credit Market Shows Signs of Cooling Following 300 Billion Issuance Surge TACHW Titan management outlines key strategic priority of pursuing highgrowth tech acquisition targets this year Paysign PAYS Q1 2026 Earnings 009 EPS Surges Past 007 Estimates Kevin Warshs Preferred Inflation Measure Faces Skepticism from Bank of America Economist Bit Digital Reports 279M Revenue but 1503M Q1 Loss Amid Crypto Mining Challenges US Senate Committee to Consider Landmark Crypto Bill This Week Solesence SLSN Stock Jumps 248 Approaching 130 20260518 StandardAero SARO Slides 407 as Selling Pressure Mounts 20260517 Jim Cramer Highlights CVS Health as Top Pick Integrated Healthcare Model in Focus Instil Bio TIL Q4 2025 Beat Revenue NA EPS Exceeds by Significant Elon Musk Loses OpenAI Lawsuit as Jury Rules Claim Filed Too Late TotalEnergies SE TTE Q1 2026 Earnings Surprise EPS 245 Up Significant Sakar Healthcare Stock Retreats from Near Record High What Investors Should Know Golar Lng GLNG Q1 2026 Beat Revenue NA EPS Exceeds by Significant KimberlyClark KMB Attracts Attention as Potentially Undervalued NASDAQ Stock LIC Bonus Record Date Approaches as PSU Stock Extends Uptrend Following Strong Earnings Credit Suisses Neelkanth Mishra Anticipates Repo Rate at Decade Low Signals Possible Market Uptick from December Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Driven by Productivity Gains and Cost Controls Evertec Inc Q1 2026 Earnings EPS Misses Estimates by 43 Stock Declines Zepp Health Q3 2025 Earnings Loss Per Share of 004 Amidst Market Challenges Pegasystems Inc PEGA Q1 2026 Earnings EPS Misses Estimates by 32 Stock Edges Higher MKTW Q1 2026 Earnings Significant EPS Miss Despite Positive Market Reaction TRINZ Q1 2026 Earnings Modest EPS Beat Amid Stable Revenue Outlook Karman Holdings KRMN Holds Near Support After Modest Decline Flag Ship Acquisition Corp Rights FSHPR Trading at 008 Amidst Stagnant Price Action Entergy Mississippi Bond EMP Holds Near Support as Yield Appeal Drives Mild Uptick The MA impact hidden in Compass COMP earnings Compass Defies Expectations with Profitable Quarter Cue Biopharma CUE Stock Why Strong Balance Sheet Smart Money Exits 20260423 Best Buy Co Inc BBY NextEra Energy NEE Q1 2026 Earnings Beat Reinforces Sustained LongTerm Growth Trajectory C4 Thera CCCC Stock Worth Considering for Investors C4 Thera posts 419 EPS beat narrower Q4 loss ORIQW Origin reports no quarterly data as newly public investment firm navigates earlystage operations ALT Altimmune reports 105 percent year over year revenue surge shares rise 176 percent despite narrow EPS miss